NYSE:DDChemicals
DuPont’s New Biopharma Materials Push Might Change The Case For Investing In DuPont de Nemours (DD)
In April 2026, DuPont’s Corian Design business introduced its 2026 “Nature in Motion” Color Collection for solid surface and quartz, while its Liveo unit launched Pharma TPE Overmolded Assemblies designed to support ultrapure fluid transfer in pharmaceutical and biopharmaceutical manufacturing.
By broadening both its design-centric surfacing portfolio and its biopharma processing solutions, DuPont is emphasizing material innovation tailored to architects, designers, and life sciences...